Kurma Partners has closed the first part of its latest biotech-focused fund, following a pair of M&A exits for drug developers backed by its third … ...
European VC firm Kurma Partners has unveiled its latest biotech fund, with 140 million euros ($154 million) raised so far and three biotech beneficiaries already named. Kurma plans to raise a ...